Evidence map›Paper›PMID 37978227›Full record

ArticleOncogene2023

Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.

L Venturutti, R I Cordo Russo, M A Rivas, M F Mercogliano, F Izzo, R H Oakley, M G Pereyra, M De Martino, C J Proietti, P Yankilevich and 9 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

L VenturuttiLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
R I Cordo RussoLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
M A RivasDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
M F MercoglianoLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
F IzzoLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
R H OakleyDepartment of Health and Human Services, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
M G PereyraLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
M De MartinoLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
C J ProiettiLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
P YankilevichInstituto de Investigación en Biomedicina de Buenos Aires, CONICET-Partner Institute of the Max Planck Society, Buenos Aires, Argentina.
J C RoaDepartamento de Anatomía Patológica (BIOREN), Universidad de La Frontera, Temuco, Chile.
P GuzmánDepartamento de Anatomía Patológica (BIOREN), Universidad de La Frontera, Temuco, Chile.
E CorteseServicio de Ginecología, Hospital Aeronáutico Central, Buenos Aires, Argentina.
D H AllemandUnidad de Patología Mamaria, Hospital General de Agudos 'Juan A Fernández', Buenos Aires, Argentina.
T H HuangDepartment of Molecular Medicine/Institute of Biotechnology, Cancer Therapy and Research Center, University of Texas, San Antonio, TX, USA.
E H CharreauLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
J A CidlowskiDepartment of Health and Human Services, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA.
R SchillaciLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina.
P V ElizaldeLaboratory of Molecular Mechanisms of Carcinogenesis, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina. patriciaelizalde@ibyme.conicet.gov.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARExperimental Medicine and Biology Institute · ARNational Institute of Environmental Health Sciences · USAdvanced Center for Chronic Diseases · CLBiomedicine Research Institute of Buenos Aires - CONICET - Partner Institute of the Max Planck Society · ARCornell University · USHospital Fernández · ARInstituto Universitario Aeronáutico · ARUniversidad de La Frontera · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37978227
OpenAlexW4388759230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.